PASG
Passage Bio·NASDAQ
--
--(--)
--
--(--)
PASG fundamentals
Passage Bio (PASG) released its earnings on Nov 10, 2025: revenue was 0 (YoY --), met estimates; EPS was -2.44 (YoY +60.65%), beat estimates.
Revenue / YoY
0
--
EPS / YoY
-2.44
+60.65%
Report date
Nov 10, 2025
EPS
Actual | -20 | -12 | -12.6 | -17 | -15.2 | -18 | -17.4 | -19 | -15.8 | -14.6 | -9.8 | -10 | -12.6 | -8.8 | -9.8 | -6 | -6 | -5.2 | -6.2 | -4 | -5 | -2.96 | -2.44 |
Forecast | -8.7153 | -11.1 | -14.75 | -13.7682 | -14.6526 | -14.6858 | -16.8566 | -17.4391 | -17.7527 | -16.6212 | -15.5445 | -10.459 | -10.7813 | -9.4667 | -9.1333 | -7.72 | -7.15 | -6.1848 | -4.6357 | -4.3 | -4.6 | -4.04 | -2.7575 |
Surprise | -129.48% | -8.11% | +14.58% | -23.47% | -3.74% | -22.57% | -3.22% | -8.95% | +11.00% | +12.16% | +36.96% | +4.39% | -16.87% | +7.04% | -7.30% | +22.28% | +16.08% | +15.92% | -33.74% | +6.98% | -8.70% | +26.73% | +11.51% |
Revenue
Actual | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Forecast | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.67M | 0 | 0 | 0 | 0 |
Surprise | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | -100.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Earnings Call
You can ask Aime
What were the key takeaways from Passage Bio's earnings call?Did Passage Bio beat or miss consensus estimates last quarter?What is the market's earnings forecast for Passage Bio next quarter?What does Passage Bio do and what are its main business segments?What is Passage Bio's latest dividend and current dividend yield?What factors drove the changes in Passage Bio's revenue and profit?What guidance did Passage Bio's management provide for the next earnings period?What is Passage Bio's gross profit margin?
